Developing a Vaccine to Help Prevent Feline Infectious Peritonitis (FIP)
Researchers will investigate a vaccine strategy against feline enteric coronavirus, a common, nonlethal virus that can mutate into feline infectious peritonitis virus.
Researchers will investigate a vaccine strategy against feline enteric coronavirus, a common, nonlethal virus that can mutate into feline infectious peritonitis virus.
Researchers will investigate genetic changes that occur in the feline enteric coronavirus that contribute to the development of feline infectious peritonitis, an incurable and fatal disease in cats.
Researchers will conduct a clinical trial to investigate the effectiveness of a novel antiviral drug in client-owned cats with naturally occurring feline infectious peritonitis as well as drug resistance that may occur during treatment.
Researchers will investigate the effectiveness of the antiviral drug famciclovir to treat and control infectious upper-respiratory disease associated with feline herpesvirus in shelter cats.
Researchers will compare combinations of antimicrobials to identify the most effective combination for use in a novel, aerosolized, nanoparticle drug delivery system.
Researchers will study subpopulations of immune cells in the blood of horses to discover new strategies to help horses fight off equine herpesvirus infections.
Researchers will investigate a new treatment strategy against antibiotic-resistant foal pneumonia.